“The Innate Immune System” Featuring Dr. Miriam Merad
On this episode of the Immunology Podcast, Dr. Miriam Merad from the Icahn School of Medicine at Mount Sinai talks about tissue-resident macrophages in COVID-19 and cancer.
Dr. Miriam Merad is a Professor of Cancer Immunology and Director of the Marc and Jennifer Lipschultz Precision Immunology Institute at the Icahn School of Medicine at Mount Sinai. Her research focuses on dendritic cells and macrophages. She talks about tissue-resident macrophages in and and bringing the international immunology community together at their upcoming meeting in South Africa.
The diversity of dendritic cells, the true story of tissue-resident macrophages, and the role of global immunology and immunologists in our modern world — this wonderful conversation has something for everyone!
Dr. Brenda Raud, co-host
Find more episodes at or wherever you get your podcasts.
This Episode's Immunology Roundup:
- – Researchers used cryo-EM to identify the structure of the active NLRP3 inflammasome disk.
- – The BCG vaccine triggers epigenetic modifications on alveolar macrophages via an intestinal microbiota-mediated pathway.
- – Scientists examined the mechanism of action of low-dose interleukin-2 immunotherapy and identified a long-lived gene expression signature associated with potential anti-inflammatory effects.
- – Researchers identified an interleukin-2 variant that retains its binding affinity in low pH environments.
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
